Skip to content

Atrial Fibrillation and Neuropathic Pain After Thoracotomy and Continuous Application of Magnesium Sulphate.

Effects of Prophylactic Administration of Magnesium Sulfate on the Incidence of Atrial Fibrillation and Chronic Neuropathic Pain After Thoracotomy for Lung Resection.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02008747
Enrollment
100
Registered
2013-12-11
Start date
2011-01-31
Completion date
2012-05-31
Last updated
2013-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Neuropathic Pain

Keywords

Atrial fibrillation, Neuropathic pain, Posterolateral thoracotomy, Lung resection

Brief summary

Atrial fibrillation and chronic neuropathic pain are adverse events occurring after posterolateral thoracotomy for lung resection. The continuous application of magnesium sulphate may have a prophylactic effect. The investigators record the incidence of atrial fibrillation during a seven day period after thoracotomy as well as the incidence of chronic neuropathic pain during a three months period, comparing one group with a continuous application of magnesium sulphate against one group without magnesium sulphate.

Interventions

DRUGMagnesium sulphate

Continuous application of magnesium sulphate applied 40 mg/kg ideal body weight by bolus before the operation started, followed by a continuous infusion of 10 mg/kg ideal body weight/h for 24 hours

Sponsors

Dr. Horst Schmidt Klinik GmbH
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * posterolateral thoracotomy for lung parenchyma resection * informed consent

Exclusion criteria

* hypersensitivity for magnesium sulphate * pre-existing atrial fibrillation * participation in another trial * pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Incidence of atrial fibrillationUp to 168 hours after operationThe incidence of atrial fibrillation was recorded using a 12 lead ECG for a period of 7 days after operation

Secondary

MeasureTime frameDescription
Chronic neuropathic painThree monthsThe incidence of neuropathic pain was recorded using the LANSS Score during a period of three months after posterolateral thoracotomy for lung resection.

Other

MeasureTime frameDescription
Hypotonia24 hours perioperativeThe incidence of hypotonia during the time of continuous magnesium sulphate application was recorded.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026